Enrolling by invitationNCT06629623

Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chu Hongling
Principal Investigator
Hongling Chu, PhD
Peking University Third Hospital
Intervention
No intervention(other)
Enrollment
310 enrolled
Eligibility
All sexes
Timeline
2024 – 2025

Study locations (1)

Collaborators

Boehringer Ingelheim · Beijing Chao Yang Hospital · Zhejiang Chinese Medical University · West China Hospital · Peking University Shenzhen Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06629623 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis →

← Back to all trials